Royal Bank Of Canada Kamada LTD Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Kamada LTD stock. As of the latest transaction made, Royal Bank Of Canada holds 37 shares of KMDA stock, worth $218. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 239 84.52%

Holding current value

$218

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.83 - $6.25 $975 - $1,262	-202 Reduced 84.52%	37 $0
Q2 2024 Aug 14, 2024	SELL	$4.78 - $5.75 $1,606 - $1,932	-336 Reduced 58.43%	239 $1,000
Q1 2024 Nov 05, 2024	BUY	$5.58 - $6.42 $1,874 - $2,157	336 Added 140.59%	575 $3,000
Q1 2024 May 15, 2024	SELL	$5.58 - $6.42 $3,721 - $4,282	-667 Reduced 53.7%	575 $3,000
Q4 2023 Feb 14, 2024	SELL	$4.14 - $6.22 $1,469 - $2,208	-355 Reduced 22.23%	1,242 $7,000
Q3 2023 Nov 14, 2023	BUY	$4.86 - $5.83 $6,692 - $8,027	1,377 Added 625.91%	1,597 $8,000
Q2 2023 Aug 14, 2023	SELL	$4.48 - $5.53 $13,807 - $17,043	-3,082 Reduced 93.34%	220 $1,000
Q1 2023 May 15, 2023	BUY	$4.12 - $5.25 $7,840 - $9,990	1,903 Added 136.03%	3,302 $15,000
Q4 2022 Feb 14, 2023	BUY	$3.79 - $4.84 $4,927 - $6,292	1,300 Added 1313.13%	1,399 $5,000
Q3 2022 Nov 14, 2022	SELL	$4.42 - $5.43 $335 - $412	-76 Reduced 43.43%	99 $0
Q2 2022 Aug 15, 2022	SELL	$4.22 - $5.85 $1,325 - $1,836	-314 Reduced 64.21%	175 $1,000
Q1 2022 May 16, 2022	BUY	$5.43 - $6.81 $1,618 - $2,029	298 Added 156.02%	489 $3,000
Q2 2021 Aug 16, 2021	BUY	$5.67 - $6.33 $1,082 - $1,209	191 New	191 $1,000

Others Institutions Holding KMDA

# of Institutions

Shares Held

6.48M

Call Options Held

200

Put Options Held

View Full List

About KAMADA LTD

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $264M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

More about KMDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Kamada LTD Transaction History